DK1110554T3 - Medicinal præparater til behandling af öjensygdomme - Google Patents

Medicinal præparater til behandling af öjensygdomme

Info

Publication number
DK1110554T3
DK1110554T3 DK99940582T DK99940582T DK1110554T3 DK 1110554 T3 DK1110554 T3 DK 1110554T3 DK 99940582 T DK99940582 T DK 99940582T DK 99940582 T DK99940582 T DK 99940582T DK 1110554 T3 DK1110554 T3 DK 1110554T3
Authority
DK
Denmark
Prior art keywords
eye diseases
medications
treatment
compositions
ocular tension
Prior art date
Application number
DK99940582T
Other languages
Danish (da)
English (en)
Inventor
Toichi Abiru
Kazuki Endo
Tomokazu Hosokawa
Miwa Misawa
Takashi Konno
Original Assignee
Yamasa Corp
Toa Eiyo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp, Toa Eiyo Ltd filed Critical Yamasa Corp
Application granted granted Critical
Publication of DK1110554T3 publication Critical patent/DK1110554T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99940582T 1998-09-01 1999-08-31 Medicinal præparater til behandling af öjensygdomme DK1110554T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24682698A JP2002173427A (ja) 1998-09-01 1998-09-01 眼疾患治療用医薬組成物

Publications (1)

Publication Number Publication Date
DK1110554T3 true DK1110554T3 (da) 2006-04-10

Family

ID=17154279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99940582T DK1110554T3 (da) 1998-09-01 1999-08-31 Medicinal præparater til behandling af öjensygdomme

Country Status (11)

Country Link
US (1) US6387889B1 (de)
EP (1) EP1110554B1 (de)
JP (1) JP2002173427A (de)
CN (1) CN1151794C (de)
AT (1) ATE319458T1 (de)
AU (1) AU5446299A (de)
CA (1) CA2342204A1 (de)
DE (1) DE69930271T8 (de)
DK (1) DK1110554T3 (de)
ES (1) ES2259842T3 (de)
WO (1) WO2000012098A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232297B1 (en) * 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
PT1150991E (pt) * 1999-02-01 2004-08-31 Univ Virginia Composicoes para o tratamento da resposta inflamatoria
US7427606B2 (en) * 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) * 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
ES2173027B2 (es) * 2000-07-06 2005-12-16 Universidad Complutense De Madrid Uso de nucleotidos en el tratamiento del glaucoma y la hipertension ocular.
WO2002020539A1 (fr) * 2000-09-08 2002-03-14 Toa Eiyo Ltd. Derives d'adenosine et leur utilisation
AU2001284485A1 (en) * 2000-09-08 2002-03-22 Toa Eiyo Ltd. Adenosine derivatives and use thereof
WO2003029264A2 (en) 2001-10-01 2003-04-10 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
ATE381336T1 (de) * 2002-04-10 2008-01-15 Univ Virginia Verwendung von a2a adenosin rezeptor agonisten und anti-pathogene mittel enthaltenden kombinationen zur behandlung von entzündungskrankheiten
WO2005097140A2 (en) * 2004-04-02 2005-10-20 Adenosine Therapeutics, Llc Selective antagonists of a2a adenosine receptors
TWI346109B (en) 2004-04-30 2011-08-01 Otsuka Pharma Co Ltd 4-amino-5-cyanopyrimidine derivatives
US7442687B2 (en) * 2004-08-02 2008-10-28 The University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
WO2006028618A1 (en) * 2004-08-02 2006-03-16 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
EP1778712B1 (de) * 2004-08-02 2013-01-30 University Of Virginia Patent Foundation 2-propynyl-adenosin-analoga mit modifizierten 5'-ribosegruppen mit a2a-agonistenaktivität
US8178509B2 (en) * 2006-02-10 2012-05-15 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) * 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
WO2008133129A1 (ja) * 2007-04-16 2008-11-06 Santen Pharmaceutical Co., Ltd. アデノシンａ２ａ受容体アゴニストを有効成分として含有する緑内障治療剤
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
EP2493480A4 (de) * 2009-10-26 2013-04-10 Inotek Pharmaceuticals Corp Ophthalmische formulierung und herstellungsverfahren dafür
AU2013296420B2 (en) 2012-08-01 2017-12-07 Lewis And Clark Pharmaceuticals, Inc. N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists
US9822141B2 (en) 2012-08-01 2017-11-21 Lewis And Clark Pharmaceuticals, Inc. N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106983B2 (ja) * 1987-12-02 1995-11-15 三共株式会社 グリゼオール酸ジエステル誘導体
EP0444196B1 (de) * 1988-11-15 1994-06-08 Yamasa Shoyu Kabushiki Kaisha Mittel zur behandlung und prophylaxe koronarer und zerebraler ischämischer erkrankungen
US5039797A (en) * 1989-10-13 1991-08-13 Yale University 2'-O-(4-benzoyl)benzoyl nucleoside cyclic monophosphate
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista

Also Published As

Publication number Publication date
AU5446299A (en) 2000-03-21
DE69930271T2 (de) 2006-08-24
CN1315862A (zh) 2001-10-03
JP2002173427A (ja) 2002-06-21
EP1110554A1 (de) 2001-06-27
ES2259842T3 (es) 2006-10-16
DE69930271D1 (de) 2006-05-04
CA2342204A1 (en) 2000-03-09
CN1151794C (zh) 2004-06-02
ATE319458T1 (de) 2006-03-15
DE69930271T8 (de) 2006-12-28
EP1110554B1 (de) 2006-03-08
US6387889B1 (en) 2002-05-14
EP1110554A4 (de) 2002-02-06
WO2000012098A1 (fr) 2000-03-09

Similar Documents

Publication Publication Date Title
DK1110554T3 (da) Medicinal præparater til behandling af öjensygdomme
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
ATE286384T1 (de) Formulierung mit verzögerter freisetzung enthaltend kollagen und glykosaminoglykan
DE69529670T2 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
ATE426413T1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
DE69630325D1 (de) Nervenschutzende für Auge von Säugern unter Anwendung von Kaliumkanalblockern
PT1040830E (pt) Medicamento para doencas neurodegenerativas
DK0799044T3 (da) Topiske oftalmologiske formuleringer indeholdende olopatidin til behandling af allergiske øjensygdomme
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
WO2002009702A8 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
ATE111736T1 (de) Okulare hypotensive mittel.
BR0210238A (pt) Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
ATE325610T1 (de) Xanthinderivative zur behandlung von hirnischämie
ATE281464T1 (de) Adenosinderivate und deren verwendung
ATE216889T1 (de) Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension
DK0871446T3 (da) Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve
BR0316775A (pt) Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
ATE204752T1 (de) Therapeutische anwendungen von 2',5'- oligoadenylat-derivaten
AU2001267864A1 (en) Remedial agent for optic nerve disease and the like
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
DE69829227D1 (de) Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
CA2219280A1 (en) Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
CY1110476T1 (el) Οφθαλμολογικα φαρμακα προστατευτικα του αμφιβληστροειδους τα οποια περιεχουν ραμιπριλη ή ραμιπριλατη